Olivetta, E
Its ability to modulate the hepatocyte growth factor (HGF)/c-Met system provides a functional platform for exploring molecular events underlying cognitive processes
This innovative strategy not only enables large-scale identification of acylcarnitines but can also be adapted for other metabolites
Pioglitazone, a diabetes medication, may benefit selected patients with biopsy-proven NASH, but is also specialist-led and off-label , with potential risks including weight gain, fluid retention, heart failure, and increased fracture risk
The benefits of antioxidants are renowned
Patients with HT may have higher numbers of miR-205, miR-296, miR-37, and miR-20a-3p in their plasma